Office of Commercialization and Economic Development
Office of Technology Commercialization

De Novo Compartment Deconvolution and Weight Estimation of Tumor Tissue Samples Using Decoder

Technology #19-0094

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Jen Jen Yeh
Managed By
Jackie Quay
Director 919.966.3929
Patent Protection
PCT Patent Application publication pending

Tumors are mixtures of different compartments. While global gene expression analysis profiles the average expression of all compartments in a sample, identifying the specific contribution of each compartment remains a challenge. With the increasing recognition of the importance of non-neoplastic components, the ability to breakdown the gene expression contribution of each is critical. DECODER, an integrated framework which performs de novo deconvolution and single-sample compartment weight estimation. Application of DECODER across cancer types advances the capability of identifying cellular compartments in an unknown sample and may have implications for identifying the tumor of origin for cancers of unknown primary.

Related Publications: